9th Session for the Indo-Swedish Joint Working Group on Health

Often referred to as the most successful MoU in our joint arsenal, the healthcare cooperation has done much to bring India and Sweden closer. Though vastly different demographically, our countries share similar challenges due to a very decentralized governance structure and a large percentage of our populations living far from health care centers. As such, many of the common challenges we face can only be overcome through collaboration and cooperation. In the coming year, ahead of the MoU's 10th anniversary, it was decided during the actual Joint Working Group meeting to take stock on what has been accomplished and explore new areas of collaboration.

For the private sector, this means we need more clarity on the recent bevy of policy changes. Although these changes for the large part have improved the business climate, they are quite confusing not only for the Swedes but Indian themselves. The Indian delegation, which included a senior representative from the Central Drugs Standard Control Organization (CDSCO), very generously shared their business cards with the Swedish companies present for the roundtable and assured each and every one of them to personally call in case of any issues.

The delegation also got a chance to see some of the Swedish products in use at Akademiska in Uppsala and was much impressed by the extremely close collaboration between professors, researchers, medical professionals, investors, and industry. While the Indian government representatives understood that these are the ingredients making Sweden such fertile ground for innovation, they had never truly appreciated how tightly, both physically and intellectually, these actors work together. This was further emphasized during their visit to EMPE Diagnostics at the Karolinska Science Park with which they ended the trip.

Going forward, Swecare, at the behest of some of our members, will focus on:

1. the inclusion of quality criteria in public healthcare tenders - looking in not just the lowest, but the total cost, and
2. exemptions based on global health threats (such as AMR which features prominently in the new Indian National Health Policy) for the price caps being introduced for certain Medtech products by the National Pharmaceutical Pricing Authority.

We are also working to ensure more continuity in our activities with India. Part of this will be through regularly planned trips to India and the cultivation of relationships with potential partners on the ground. If you have any suggestions or requests, do get in touch. India is a vast, and often overwhelming, country but the rewards for successful partnership could eventually affect the national and global health threats facing both Sweden and India - not to mention improve the lives of people.

Candid discussions on facilitating Swedish access to - and success in - the dynamic Indian market

Sometimes the best ideas emerge from meetings without agendas, and the most exciting initiatives while you are trying to get from one place to the next. Inspiring colleagues and partners do not hurt either.

The Indo Swedish Joint Working Group on Health meeting, which was supposed to take place yesterday, was cancelled due to reasons beyond the control of its participants. Our partner, colleague, and friend from Delhi, who has been at the Swedish Embassy there for almost 22 years, came regardless and tried to maintain a part of the program drawn up for the JWG delegation.

Yasmin Roy-Zaveri's week started at a roundtable organised by the Sweden India Business Council and hosted by Swecare, during which pharma and medtech companies came face to face with a high-level delegation from the Department of Industrial Policy and Promotion, led by Additional Joint Secretary Atul Chaturvedi - accompanied by the Indian Embassy in Stockholm, Invest India, and the Confederation of Indian Industry. During this open and frank discussion, the key question was asked as to how can India make things easier for Swedish companies to enter the market. Clearly the country is eager to make the necessary changes and indeed has already taken many steps in this direction, including the recent change in policy as regards to medical devices.

This roundtable, which was followed by a delicious dinner at India House, was a precursor to the 'Make in India' event planned in Stockholm October 12-13. The first of its kind, this two day exhibit will showcase the success and potential of the Indian market.

Tuesday morning was much more low-key, and quite fruitful, as the day began with the H2 Health Hub breakfast. Yasmin, Johan from the Swedish Ministry of Health, and Swecare sat with the founders of H2 and some of its members to brainstorm  on ideas through which we could complement each other's work and make our contributions more meaningful. Some extremely exciting project concepts came out of the three hours spent there (no one wanted to leave) - so do watch this space for updates!

The day ended with a meeting at Karolinska Institute's International Relations Unit where we discussed the progress, challenges, and potential for partnerships with India. Yasmin's trip was rounded off with meetings at the Ministry of Health and with some of the agencies who have been collaborating under the Indo-Swedish MoU on Health.

It was generally agreed that the time to act in India was now. The government, with its new Health Policy, has increased its contribution to the Health System. And while the going may be slow at times, the effort is worth it. Also, you are not alone. Swecare and Yasmin at the Embassy of Sweden in Delhi is always here to help.


With that, we at Swecare wish you a wonderful Midsummer!